1. Absi, Adelstein, Rice. 2010. Esophageal Cancer.

The Cleveland Clinic

Foundation. (available at:
http://www.clevelandclinicmeded.com/medicalpubs/diseasemanagement/h
ematology-oncology/esophageal-cancer/. Diakses 22 April 2014)
2. Adib, A 2012. Allah Mennurunkan Penyakit dan Obatnya. Al Madinah,
Surakarta. (Available at: http://almadinah.or.id/483-allah-menurunkanpenyakit-dan-obatnya.html). Diakses pada 09 November 2015.
3. Alberts, Johnson, Lewis, Raff, Roberts, Waiter. 2002. Isolating, Cloning,
and Sequencing DNA in Molecular Biology of the Cell. Ed.4. (Available
at: http://www.ncbi.nlm.nih.gov/books/NBK26837. Diakses tanggal: 4
Desember 2015).
4. Al-Quran dan Terjemahannya. 2010. Departemen Agama Republik
Indonesia, Jakarta.
5. Arsana IP, Wibawa IDN. 2010. Seorang penderita dengan karsinoma sel
skuamus esofagus. J Peny Dalam, Vol.11 Nomor 1 Januari 2010.
6. American Cancer Society, 2013. Esophagus Cancer. American Cancer
Society. (Available at:
http://www.cancer.org/acs/groups/cid/documents/webcontent/003098pdf.pdf. Diakses pada 28 Maret 2014.)
7. Az Zahrani, Musfir bin Said 2005. Proses Pencerapan: Konseling
Terapi, hal. 271 273. Penerbit Gema Insani.
8. Bahrein. 2011. Orang yang sakit selayaknya Bergembira. Muslimafiyah.
(Available

at:

http://muslimafiyah.com/orang-yang-sakit-selayaknya-

bergembira.html#_ftn5. Diakses pada 20 November 2015).

9. Buskens, Marsman, Wesseling, Offerhaus, Yamamoto, Curiel, Bosma, van
Lanschot. 2003. A genetically retargeted adenoviral vector enhances viral
transduction in esophageal carcinoma cell lines and primary cultured

esophageal resection specimens. Annals of Surgery, Vol. 238, Number 6,

December 2003.
10. Chen G, Zhang S, Liu S, Ma C, Zou XP. 2014. Clinical utility of
recombinant adenoviral human p53 gene therapy: current perspectives.
Onco Targets and Therapy 2014:7 1901-1909.
11. Daradjat Z et al. 1984. Masalah Makhluk: Dasar Dasar Agama Islam,
Buku Teks Pendidikan Agama Islam pada Perguruan Tinggi Umum, hal. 2
50. Penerbit Bintang bintang, Jakarta.
12. Fontana L, Nuzzo M, Urbanelli L, Monaci P. 2003. General Strategy for
broadening adenovirus tropism. Journal of Virology, Oct.2003, p.11094
11104.2003.
13. Gelberg, H. 2014. Comparative anatomy, physiology, and mechanism of
disease production of the esophagus, stomach, and small intestine.
Toxicologic Pathology, 42, 54-66,2014.
14. Genentech, 2014. Molecular Causes of Cancer. Genentech USA.
(available at: http://www.biooncology.com/molecular-causes-of-cancer.
Diakses pada 4 April 2014).
15. Guo M, Jia YJ, Yan W. 2012. Molecular biology character of esophageal
cancer, Esophageal cancer cell and molecular biology, biomarkers,
nutrition and treatment, Prof. Ferdous Rastgar Jazii (Ed.). InTech.
(Available at: http://www.intechopen.com/books/esophageal-cancer-celland-molecular-biology-biomarkers-nutrition-and-treatment/molecularbiology-character-of-esophageal-cancer. Diakses pada tanggal: 15 Juli
2015)
16. Haerudin, M 2013. Islam dan Akal Manusia. Kompasiana, Jakarta.
(Available at: http://filsafat.kompasiana.com/2012/05/17/islam-dan-akalmanusia-463591.html). Diakses pada 09 November 2015.

17. Harada H, Nakagawa H, Oyama K, Takaoka M, Andi CD, Jacobmeier B,

von Werder A, Enders GH, Oplitz OG, Rustgi AK. 2003. Telomerase
induces immortalization of human esophageal keratinocytes without
p16INK4a inactivation. Molecular Cancer Research Vol.1; 729 738,
August 2003.
18. Hejmadi. 2010. Introduction to cancer biology. 2010 Hejmadi &
Bookbon.com.(Available

at:

http://csbl.bmb.uga.edu/mirrors/JLU

/DragonStar2015 /download/introduction-to-cancer-biology.pdf. Diakses

tanggal: 20 Juni 2014).
19. Hesse A, Kosmides D, Kontermann RE, Nettelbeck DM. 2007. Tropism
modification of adenovirus vectors by peptide ligand insertion into
various positions of the adenovirus seroptype 41 short-fiber knob domain.
Journal of Virology, Mar 2007, p.2688 2699.
20. Holmes, Rosenberg, Valerie. 2003. Adenovirus expressing p53, Methods
in Molecular Biology,vol.234: p53 protocols, Sumitra Deb, Swati Palit
Deb (Ed.). Humana Press Inc.: New Jersey.
21. International Agency for Research on Cancer (IARC). 2012. Globocan
2012: Estimated Cancer Incidence, Mortality and Prevalence Worldwide
in 2012. World Health Organization. (available at:
http://globocan.iarc.fr/Pages/fact_sheets_cancer.aspx. Diakses pada 28
Maret 2014).
22. Jobe, Thomas Jr., Hunter. 2009. Esophageal cancer: principles and
practice. Demos Medical Publishing: USA.
23. Jounaidi Y, Doloff JC, Waxman DJ. 2007. Conditionally Replicating
Adenoviruses for Cancer Treatment. Current Cancer Drug Targets, 2007,
7,285-301.
24. Kamal, Abu Malik. 2011. Fiqih Sunah Wanita. Madina Adipustaka.

25. Kamangar F, Chow W, Abnet C, Dawsey S. 2009. Environmental causes

of esophageal cancer. Gastrointestinal Clin North Am. 2009 March;
38(1):27.
26. Kessler T, Hendrik H, Christoph W. 2013. Integrative analysis of cancerrelated signaling pathways. Frontiers in Physiology vol. 04, 2013.
27. Lagergren, J; Lagergren P.2013. Recent developments in esophageal
adenocarcinoma. Ca Cancer J Clin 2013; 6: 232-248.
28. Luo J, Deng Z, Luo X, Tang N, Song WX, Chen J, Sharff KA, Luu HH,
Haydon RC, Kinzler KW, Vogelstein B, He TC. 2007. A protocol for
rapid generation of recombinant adenoviruses using the AdEasy system.
Nature Protocols Vol. 2 No.5, 2007.
29. Ma G, Kawamura K, Li Q, et al. 2009. Cytotoxicity of Adenoviruses
expressing the wild-type p53 gene to esophageal carcinoma cells is linked
with the CAR expression level and indirectly with the endogenous p53
status. Cancer Gene Therapy (2009) 16, 832-840.
30. Komisi Fatwa Majelis Ulama Indonesia. 2009. Keputusan fatwa komisi
fatwa majelis ulama Indonesia tentang penetapan produk halal. Majelis
Ulama Indonesia: Jakarta.
31. Makmun D, Simadibrata M, Abdullah M, Syam AF, Fauzi A, Renaldi K,
Rani A, Krisnuhoni E. 2014. Changing trends in gastrointestinal
malignancy in Indonesia: The Jakarta experience. J Cancer Res Ther
2014, 2 (9):160 168.
32. Mardiani, Dian & Djannatun, Titiek. 2013. Viroterapi sebagai terapi
kanker. Pharmamedika vol. 05,2013.
33. National Cancer Institute, 2012. Esophageal Cancer Treatment. National
Cancer Institute. (Available at:
http://www.cancer.gov/cancertopics/pdq/treatment/esophageal/HealthProf
essional/page1. Diakses pada 28 Maret 2014).

34. Park JC, Moon C. 2008. Gene therapy for esophageal cancer. Cancer
Therapy Vol.6,35-46,2008.
35. Pat J, Gold JS, unshi NC, Shammas MA. 2013. Biology of telomeres:
Importance in etiology of esophageal cancer and as therapeutic target.
Transl Res. 2013 December; 162(6).
36. Rauschhuber CT. 2011. Analysis of adenovirus-host interactions to
improve recombinant adenoviral vectors for gene therapy. LudwigMaximillians University: Munich.
37. Robert, Michel, Flaman, et al. 2000. High frequency of esophageal
Cancer of p53 alterations inactivating the regulation of genes involved in
cell cycle and apoptosis. Carcinogenesis, 21,563-565.
38. Ross PJ, Parks RJ. 2009. Construction and characterization of adenovirus
vectors. Cold Spring Harb ProtocVol. 4, issue 5, May 2009.
39. Roy Chowdury J, Horwitz MS. 2002. Evolution of adenovirus as gene
therapy vectors. Molecular Therapy Vol.5, No.4, April 2002.
40. Sharma A, Li X, Bangari DS, Mittal SK. 2009. Adenovirus receptors and
their implications in gene delivery. Virus Res. 2009 August; 143(2):184194.
41. Shimada H, Matsubara H, Shiratori T, Shimizu T, Miyazaki S, Okazumi
S, Nabeya Y, Shuto K, Hayashi H, Tanizawa T, Nakatani Y, Nakasa H,
Kitaada M, Ochiai T. 2006. Phase I/II adenoviral p53 gene therapy for
chemoradiation resistant advanced esophageal squamous cell carcinoma.
Cancer Sci, Vol. 97, No.6, June 2006: 554-561.
42. Shors, Teri. 2011. Understanding viruses, 2nd ed. USA: Jones & Bartlett
Learning, LLC.
43. Stahl, et al. 2010. Esophageal cancer: Clinical Practice Guidelines for
diagnosis, treatment and follow-up. Annals of Oncology 21 (supplement
5):v46-v49 (2010).

44. Sun YL, Xie H, Lin HL, Feng Q, Lin Y. 2015. Construction and
identification of recombinant adenovirus carrying human TIMP-1shRNA
gene. Genetics and Molecular Research 14 (1):199 208 (2015).
45. Tan R, Li C, Jiang S, Ma L. 2006. A novel and simple method for
construction of recombinant adenoviruses. Nucleic Acids Research, 2006,
Vol. 34, No.12.
46. Tanaka, Kuroki, Hamada, Kato, Kinugasa, Shibaguchi, Zhao, Kuroki M.
Cancer-targeting gene therapy using tropism-modified adenovirus.
Anticancer Research 27: 3679-3684 (2007).
47. Tang & Hickey. 2014. Cell cycle and cell division. Nature Publishing
Group. (Available at: : http://www.nature.com/scitable/topic/cell-cycleand-cell-division-14122649 Diakses tanggal: 12 November 2015).
48. Torre LA, Bray F, Siegel RL, Ferlay J, Lortet Tieulent J, Jemal A. 2015.
Global Cancer Statistics, 2012. Ca Cancer J Clin 2015,65:87 108.
49. Van Hagen, Hulshof, van Lanschot, et al. 2012. Preoperative
chemoradiotherapy for esophageal or junctional cancer . N Engl J Med
366;22.
50. Viswanatha D. 2015. Esophagus anatomy. Medscape. (available at:
http://emedicine.medscape.com/article/1948973. Diakses tanggal: 19
November 2015).
51. Viswanathan S, Srinivasan, Prabhu S. 2015. Adenoviruses in gene therapy
A review. Bioengineering and Bioscience 3(1):1 5, 2015.
52. Watanabe N, Shimizu M, Kochi T, Shirakami Y, Tanaka T. 2014.
Esophageal carcinogenesis. Open Journal of Pathology, 2014, 4, 151170.
53. Williams & Stoeber. 2012. The cell cycle and cancer. Journal Of
Pathology 2012; 226: 352 364.
54. Wong, Lemoine, Wang. 2010. Oncolytic viruses for cancer therapy:
Overcoming the obstacles. Viruses 2010, 2, 78 106.

55. Yang S, Kawamura K, Okamoto S, Yamauchi S, Shingyoji M, Sekine I,

Kobayashi H, Tada Y, Tatsumi K, Hiroshima K, Shimada H, Tagawa M.
2015. Cytitixic effects of replication-competent adenovirus on huma
esophageal carcinoma are enhanced by forced p53 expression. BMC
Cancer (2015) 15:464.
56. Yang, Xu, Shen, Yang, Wu, Xioa, Xu, Liu, Chu. 2015. RGD-modified
oncolytic adenovirus exhibited potent cytotoxic effect on AR-negative
bladder cancer-initiating cells. Cell Death and Disease (2015)6, e 1760.
57. Yu W, Fang H. 2007. Clinical trials with oncolytic adenvirus in China.
Curr Cancer Drug Targets. 2007 Mar;7(2):141-8.
58. Zare M, Moghanibashi M, Jazii FR. 2012. Growth factors, signal
transduction pathways, and tumor suppressor genes in esophageal cancer,
Esophageal cancer cell and molecular biology, biomarkers, nutrition,
and treatment, Prof. Ferdous Rastgar Jazii (Ed.). InTech. (Available at:
http://www.intechopen.com/books/esophageal-cancer-cell-and-molecularbiology-biomarkers-nutrition-and-treatment/molecular-biology-characterof-esophageal-cancer. Diakses pada tanggal: 15 Juli 2015)
59. Zhang Y. 2013. Epidemiology of esophageal cancer. World Journal of
Gastroenterology 2013 September 14;19(34): 5598-5606.
60. Zhang, Bergelson. 2005. Adenovirus receptors. Journal of Virology, Oct.
2005, Vol. 79, No. 19 p. 1212512131.
61. Zuhri, Saifudin 2012. Kewajiban Menuntut Ilmu. Asy Syariah Online,
Jakarta.

(Available

at:

http://asysyariah.com/kewajiban-menuntut-

ilmu.html). Diakses pada 09 November 2015.

62. Zuhroni 2010. Manusia: Dasar dan Sumber Syariat Islam, hal. 27 46.
Bagian Agama Islam Universitas YARSI, Jakarta.
63. Zuhroni 20101. Makhluk: Dasar dan Sumber Syariat Islam, hal. 24 26.
Bagian Agama Islam Universitas YARSI, Jakarta.

64. Zuhroni 20102. Kedokteran Dalam Islam: Pandangan Islam terhadap

Masalah Kedokteran dan Kesehatan, hal 1- 24. Bagian Agama Islam
Universitas YARSI, Jakarta.